Niagen Bioscience Files Prospectus To Offer And Sell Common Stock Up To $50M

Benzinga Newsdesk www.benzinga.com Neutral 92.2%

Neg 0% Neu 92.2% Pos 0%

https://www.sec.gov/Archives/edgar/data/1386570/000121390026077234/ea0297322-424b5_niagen.htm

Comments

No comments yet. Be the first!